Universal Biosensors Inc (UBI):企業の財務・戦略的SWOT分析

◆英語タイトル:Universal Biosensors Inc (UBI) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME7173FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥32,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥48,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Universal Biosensors Inc (UBI) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Universal Biosensors Inc (UBI) is an in vitro diagnostic company which develops, designs electrochemical cell technology platform used in various industries including food and drink, healthcare and agriculture. UBI is working with Siemens Healthcare to develop a range of products for the point-of-care coagulation market and will manufacture test strips for these products. The company’s focus areas include coagulation testing, blood glucose testing and other electromechanical cell based tests. It manages its research and development, and manufacturing operations through its subsidiaries located in British Columbia, Canada and Melbourne, Australia. UBI is headquartered in Melbourne, Victoria, Australia.

Universal Biosensors Inc Key Recent Developments

Mar 17,2021: Universal Biosensors – Resignation of Director – Marshall Heinberg
Dec 30,2020: UBI’s Canadian subsidiary signs deal with Bayer AG
Nov 04,2020: UBI receives $2.8 million under the R&D Tax Incentive Rebate
Oct 19,2020: Universal Biosensors : September 2020 quarterly activity report

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Universal Biosensors Inc – Key Facts
Universal Biosensors Inc – Key Employees
Universal Biosensors Inc – Key Employee Biographies
Universal Biosensors Inc – Major Products and Services
Universal Biosensors Inc – History
Universal Biosensors Inc – Company Statement
Universal Biosensors Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Universal Biosensors Inc – Business Description
Business Segment: Products Revenue
Overview
Performance
Business Segment: Service Revenue
Performance
R&D Overview
Universal Biosensors Inc – Corporate Strategy
Universal Biosensors Inc – SWOT Analysis
SWOT Analysis – Overview
Universal Biosensors Inc – Strengths
Universal Biosensors Inc – Weaknesses
Universal Biosensors Inc – Opportunities
Universal Biosensors Inc – Threats
Universal Biosensors Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Universal Biosensors Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Universal Biosensors Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Universal Biosensors Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 17, 2021: Universal Biosensors – Resignation of Director – Marshall Heinberg
Dec 30, 2020: UBI’s Canadian subsidiary signs deal with Bayer AG
Nov 04, 2020: UBI receives $2.8 million under the R&D Tax Incentive Rebate
Oct 19, 2020: Universal Biosensors : September 2020 quarterly activity report
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Universal Biosensors Inc, Key Facts
Universal Biosensors Inc, Key Employees
Universal Biosensors Inc, Key Employee Biographies
Universal Biosensors Inc, Major Products and Services
Universal Biosensors Inc, History
Universal Biosensors Inc, Subsidiaries
Universal Biosensors Inc, Key Competitors
Universal Biosensors Inc, Ratios based on current share price
Universal Biosensors Inc, Annual Ratios
Universal Biosensors Inc, Annual Ratios (Cont...1)
Universal Biosensors Inc, Annual Ratios (Cont...2)
Universal Biosensors Inc, Interim Ratios
Universal Biosensors Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Universal Biosensors Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Universal Biosensors Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Universal Biosensors Inc (UBI):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Stage Stores Inc:戦略・SWOT・企業財務分析
    Stage Stores Inc - Strategy, SWOT and Corporate Finance Report Summary Stage Stores Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Western Iowa Energy LLC:企業の戦略的SWOT分析
    Western Iowa Energy LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Royal College of Surgeons Ireland-製薬・医療分野:企業M&A・提携分析
    Summary Royal College of Surgeons Ireland (RCSI) is a not-for-profit organization that offers medical education and training in healthcare professions at undergraduate and postgraduate levels. The organization offers undergraduate courses in nursing, postgraduate research, postgraduate taught, leade …
  • East Japan Railway Co:企業の戦略・SWOT・財務分析
    East Japan Railway Co - Strategy, SWOT and Corporate Finance Report Summary East Japan Railway Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Paychex, Inc.:企業の戦略・SWOT・財務情報
    Paychex, Inc. - Strategy, SWOT and Corporate Finance Report Summary Paychex, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Verbund AG (VER):電力:M&Aディール及び事業提携情報
    Summary Verbund AG (Verbund) is an electricity utility that generates, transmits, trades, and distributes electricity. It generates from renewable energy sources such as hydropower, biomass, wind, and solar power. The company constructs, operates and maintains power plants; trades electricity and ga …
  • Gfk SE (GFK):企業の財務・戦略的SWOT分析
    Summary GfK SE (GfK) is a business service provider that offers market and consumer services. The company provides solutions such as online pricing intelligence, brand and customer experience, point of sales analytics, digital marketing intelligence, consumer panels, product catalogs, market opportu …
  • Sulzer Ltd (SUN)-エネルギー分野:企業M&A・提携分析
    Summary Sulzer Ltd (Sulzer) is an industrial engineering company that manufactures and supplies pump equipment. It offers mixers, compressors, agitators and aeration equipment. The company provides repair and maintenance service solutions for turbines, pumps, compressors, motors, and generators. Sul …
  • Trinity Exploration and Production plc (TRIN):石油・ガス:M&Aディール及び事業提携情報
    Summary Trinity Exploration and Production plc (Trinity), formerly Bayfield Energy Holdings plc is an oil and gas company that explores and develops onshore and offshore projects. The company’s activities include production, development, exploration and extraction of hydrocarbons. It operates in Tri …
  • Noile-Immune Biotech Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Noile-Immune Biotech Inc (Noile-Immune Biotech) is a clinical stage biotechnology company that develops and commercializes next generation CAR-T cell therapies for the treatment of cancer. The company works in collaboration with National Cancer Center Japan and Yamaguchi University to develo …
  • MEC Holding GmbH:企業の戦略的SWOT分析
    MEC Holding GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Seres Therapeutics Inc (MCRB):企業の財務・戦略的SWOT分析
    Summary Seres Therapeutics Inc (Seres), is a microbiome therapeutics platform company that develops a novel class of biological drugs. The company creates a new class of medicines to treat diseases resulting from functional deficiencies in the microbiome, a condition known as dysbiosis. The company’ …
  • Daewoong Pharmaceutical Co Ltd (069620):企業の財務・戦略的SWOT分析
    Daewoong Pharmaceutical Co Ltd (069620) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • SIFI SpA-製薬・医療分野:企業M&A・提携分析
    Summary SIFI SpA (SIFI) is an integrated ophthalmic company that focuses on eye care products. It develops, manufactures and markets pharmaceutical products, diagnostic instruments and surgical equipment for the prevention and treatment of the most common ocular pathologies. SIFI develops its produc …
  • Izocam Tic Ve San AS:企業の戦略・SWOT・財務情報
    Izocam Tic Ve San AS - Strategy, SWOT and Corporate Finance Report Summary Izocam Tic Ve San AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Haitong Securities Co., Ltd.:企業の戦略・SWOT・財務分析
    Haitong Securities Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Haitong Securities Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • University of Texas Southwestern Medical Center-製薬・医療分野:企業M&A・提携分析
    Summary University of Texas Southwestern Medical Center (UTSMC), a subsidiary of University of Texas System is an educational center that offers medical research and education programs. The center offers degree programs, which include master's degree in business administration, public health, medica …
  • SSY Group Ltd (2005):企業の財務・戦略的SWOT分析
    Summary SSY Group Ltd (SSY), Subsidiary of China Pharmaceutical Company Limited, is a pharmaceutical company that offers range of pharmaceutical products such as intravenous infusion solution. The company offers glass bottle infusion solutions, non-PVC soft bag infusions, and PP plastic bottle infus …
  • TClarke Plc (CTO):企業の財務・戦略的SWOT分析
    TClarke Plc (CTO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Suda Pharmaceuticals Ltd (SUD):企業の財務・戦略的SWOT分析
    Summary Suda Pharmaceuticals Ltd (Suda Pharmaceuticals), formerly Suda Ltd is a drug delivery company that offers oro-mucosal administration solutions. The company offers products such as SUD-001, SUD-002, SUD-003, SUD-004 and SUD-005, artimist, and zolpimist. Its artimist is a sub-lingual spray for …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆